Daewoong Pharmaceutical Co Ltd
Daewoong Pharmaceutical Co., Ltd. is a South Korean pharmaceutical firm headquartered in Seoul. It provides prescription medications, non-prescription drugs, healthcare goods, and APIs. The company manufactures tablets, capsules, ointments, injections, liquids, and sprays. It provides cures for bone and joint disorders, cardiovascular diseases, central nervous system diseases, circulatory system, dermatological, gastrointestinal, and respiratory system conditions. It also handles product development and commercialization via in-licensing, co-marketing, and co-promotion. In Asia, the corporation operates in Japan, the United States, Canada, Switzerland, and Germany, in addition to Indonesia, China, Vietnam, Israel, Thailand, and India.
Daewoong Pharmaceutical Co., Ltd., founded in 1945, has the highest prescription medicine sales in Korea and aspires to be a top 50 worldwide healthcare firm by 2010. Daewoong has developed a strong core competency for innovative medication development and created a cooperative culture for working with worldwide partners in addition to its product portfolio, which includes ten blockbuster drugs.
The company's purpose is to provide the most beneficial overall solutions with drugs and services that contribute to the improvement of valued consumers' quality of life. Daewoong Pharmaceutical will develop its global business with international branches and global partners in the future to become a global healthcare group that contributes to enhancing the quality of life for people all over the world.
Founded: 1945
Headquarters: Seoul, South Korea
Website: https://www.daewoong.co.kr/
